Recent news on Epirubicin

Making Science Personal: Lilly Oncology to Unveil 76 Studies at ...  -  May 23, 2007
campus med,2:00 pm -- Neoadjuvant chemotherapy with a dose-dense sequential combination of epirubicin and cyclophosphamide followed by paclitaxel and gemcitabine

YM BioSciences reports third quarter 2007 operational and ...  -  May 11, 2007
CNW Telbec (Communiqués de presse),...with epirubicin and cyclophosphamide for the treatment of rapidly progressing metastatic breast cancer completed the third planned interim analysis.

Xeloda Approved in Europe for the Treatment of Advanced Stomach Cancer  -  Mar 29, 2007
campus med,The approval of Xeloda in combination with platinum-based chemotherapy (with or without epirubicin), was based on two trials, called ML17032 and REAL 2.

Taxane Use And Dose-Dense Scheduling May Benefit Patients With ...  -  Apr 14, 2007
Medical News Today (press release),Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 trial.

APS: Xeloda Approved in Europe for the Treatment of Advanced .....  -  Mar 29, 2007
ANP Pers Support,...without epirubicin), was based on two trials, called ML17032 and REAL 2. Both these. as those on the 5-FU arms. In fact, the REAL 2 study showed patients on

Oral Cancer Drug Xeloda Receives Positive Opinion from the ...  -  Feb 23, 2007
PharmaLive.com (press release),The study showed that patients treated with the combination of Xeloda plus oxaliplatin and epirubicin (EOX) live significantly longer, compared to patients

YM BioSciences ends breast cancer trial  -  Feb 1, 2007
Pharmaceutical Business ReviewThe phase III trial compared the survival of patients treated with tesmilifene combined with epirubicin/cyclophosphamide to epirubicin/cyclophosphamide

YM BioSciences drug trial stopped; CEO says company has cash ...  -  Jan 31, 2007
Canada.com,The trial compares the survival of patients treated with tesmilifene combined with epirubicin-cyclophosphamide to epirubicin-cyclophosphamide alone in women

YM BioSciences Halts Breast Cancer Trial  -  Jan 30, 2007
Forbes,...spreading and/or recurrent breast cancer treated with either tesmilifene combined with epirubicin/cyclophosphamide or epirubicin/cyclophosphamide alone.

Pro-Pharmaceuticals Collaborates with Chemwerth to Scale-up ...  -  Feb 20, 2007
PharmaLive.com (press release),Cisplatin USP, Doxorubicin HCl USP, Epirubicin HCl EP, Etoposide USP, Fludarabine Phosphate, Gemcitabine HCl USP, Ifosfamide USP, Irinotecan HCl 3H2O,

YM Biosciences Reports Second Quarter 2007 Operational and ...  -  Feb 9, 2007
CNW Telbec (Communiqués de presse),...with epirubicin and cyclophosphamide for the treatment of rapidly progressing metastatic breast cancer completed the third planned interim analysis.

Ym BioSciences reaches milestones in cancer trial  -  Jan 15, 2007
Globe and Mail,The trial compares the survival of patients treated with tesmilifene combined with epirubicin-cyclophosphamide to epirubicin-cyclophosphamide alone in women

YM BioSciences' breast cancer Rx advancing  -  Jan 15, 2007
United Press InternationalThe 723-patient, phase 3 trial is being done to compare the survival of patients treated with tesmilifene combined with epirubicin/cyclophosphamide to

YM Biosciences' breast cancer drug reaches milestone in Phase III ...  -  Jan 15, 2007
Hemscott,The Phase III trial compares results from patients treated with a mixture of tesmilifene and epirubicin/cyclophosphamide against those treated with just

Follow-Up Data on Dose-Dense Chemotherapy Confirms Benefit in ...  -  Jan 10, 2007
Cancer Consultants (press release),Patients were randomized to dose-dense therapy (epirubicin 150 mg/m2, paclitaxel 225 mg/m2 and cyclophosphamide 2500 mg/m2) administered once every 2 weeks

YM BioSciences Provides Update On Tesmilifene Pivotal Trial  -  Jan 16, 2007
Medical News Today (press release),The pivotal Phase III trial compares the survival of patients treated with tesmilifene combined with epirubicin/cyclophosphamide to

YM BioSciences provides update on tesmilifene pivotal trial  -  Jan 15, 2007
Drug Newswire (press release),The pivotal Phase III trial compares the survival of patients treated with tesmilifene combined with epirubicin/cyclophosphamide to

Follow-up Data on Dose-dense Chemotherapy Confirm Benefit in Early ...  -  Dec 22, 2006
Cancer Consultants (press release),Patients were assigned to receive either dose-dense or conventional chemotherapy with epirubicin, cyclophosphamide, and paclitaxel.

Re-Induction Chemotherapy May Improve Survival for Some Patients ...  -  Jan 2, 2007
Cancer Consultants (press release),This trial included 48 patients who were all initially treated with 6 courses of PEV (Platinol® (cisplatin), Ellence® (epirubicin), Navelbine® (vinorelbine)

Epirubicin-Based Regimen Treats Inflammatory Breast Cancer  -  Dec 19, 2006
Cancerpage.com,NEW YORK DEC 18, 2006 (Reuters Health) - Epirubicin-based induction and maintenance chemotherapy leads to relatively high long-term survival rates in women

Doxorubicin/Cyclophosphamide Followed by Paclitaxel Inferior to ...  -  Dec 18, 2006
DG NewsThe National Cancer Institute of Canada's (NCIC) MA.21 trial is comparing 3 chemotherapy combinations involving epirubicin or doxorubicin in premenopausal

Follow-up Data on Dose-dense Chemotherapy Confirm Benefit in Early ...  -  Dec 22, 2006
Cancer Consultants (press release),Patients were assigned to receive either dose-dense or conventional chemotherapy with epirubicin, cyclophosphamide, and paclitaxel.

Health Highlights: Dec. 18, 2006  -  Dec 18, 2006
Forbes,...epirubicin and fluorouracil), and EC/T (a shorter, concentrated course of epirubicin and cyclophosphamide followed by paclitaxel), the Canadian Press

New Data On Pfizer's Aromasin and Ellence to Be Presented at San ...  -  Dec 14, 2006
Earthtimes.orgEllence (epirubicin hydrochloride injection) is part of a chemotherapy regimen used to treat the early stages of breast cancer when the cancer has spread to

Longer infusion times for anthracyclines reduce cardiac damage  -  Nov 29, 2006
TheHeart.Org,The majority of patients were adults with different types of solid tumors, and the drugs used were doxorubicin, daunorubicin, and epirubicin.

Drug Stocks End Short Week Lower  -  Nov 27, 2006
Forbes,21 it forged an agreement with Pfizer (nyse: PFE - news - people ) regarding the generic sales of idarubicin, azithromycin and epirubicin.

Ten-year Survival of Patients with Localized Inflammatory Breast ...  -  Nov 27, 2006
Cancer Consultants (press release),Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy. Ten year results from the French Adjuvant Study Group GETIS

New Data On Pfizer's Aromasin and Ellence to Be Presented at San ...  -  Dec 14, 2006
PR Newswire (press release),About Ellence(R) Ellence (epirubicin hydrochloride injection) is part of a chemotherapy regimen used to treat the early stages of breast cancer when the

Abraxis BioScience to present data from six studies at San Antonio ...  -  Dec 11, 2006
CNW Telbec (Communiqués de presse),5:00 pm- 7:00 pm Preliminary results from a multicenter phase II trial of biweekly neoadjuvant gemcitabine, epirubicin, ABI-007 (GEA) with correlative

Anthracyclines May Not Be For Everyone: Report From The 29th ...  -  Dec 19, 2006
Medical News Today (press release),The anthracycline drugs used as a standard component of chemotherapy for breast cancer patients (doxorubicin and epirubicin) may cause serious side effects,

New Canadian-led study shows widely-used breast cancer treatment ...  -  Dec 18, 2006
CNW Telbec (Communiqués de presse),...known as CEF (the Canadian-developed protocol), and EC/T (an experimental protocol), both of which include epirubicin (trade name PHARMORUBICIN(*)).

Anthracyclines May Not Be for Everyone: Report From the 29th ...  -  Dec 18, 2006
PR Newswire (press release),18 /PRNewswire/ -- The anthracycline drugs used as a standard component of chemotherapy for breast cancer patients (doxorubicin and epirubicin) may cause

Additional Chemotherapy May Improve Survival for Some Patients ...  -  Dec 18, 2006
Cancer Consultants (press release),This trial included 48 patients who were all initially treated with the chemotherapy drugs Platinol® (cisplatin), Ellence® (epirubicin), and Navelbine®

New Canadian-led Study Shows Widely-used Breast Cancer Treatment ...  -  Dec 18, 2006
PharmaLive.com (press release),...known as CEF (the Canadian-developed protocol), and EC/T (an experimental protocol), both of which include epirubicin (trade name PHARMORUBICIN*).

Chemo regimen found inferior  -  Dec 18, 2006
Globe and Mail,EC/T, epirubicin and cyclophosphamide followed by paclitaxel, a newer experimental approach that is not widely used. After tracking the patients for at

Anthracyclines May Not Be for Everyone: Report From the 29th ...  -  Dec 18, 2006
PharmaLive.com (press release),...as a standard component of chemotherapy for breast cancer patients (doxorubicin and epirubicin) may cause serious side effects, including heart damage.

Anthracyclines May Not Be for Everyone: Report From the 29th ...  -  Dec 18, 2006
Earthtimes.org18 -- The anthracycline drugs used as a standard component of chemotherapy for breast cancer patients (doxorubicin and epirubicin) may cause serious side

Zoek in het archief  -  Dec 17, 2006
Netherlands Corporate News (persbericht),ABRAXANE) followed by 5-fluorouracil, epirubicin and cyclophosphamide (FEC) in locally advanced breast cancer (LABC): a phase II trial of the NSABP

Attention Business/News Editors:  -  Dec 17, 2006
Canada NewsWire (press release),Abraxane) followed by 5-fluorouracil, epirubicin and cyclophosphamide (FEC) in locally advanced breast cancer (LABC): a phase II trial of the NSABP

Breast Cancer Regimen Linked to Cognitive Decline  -  Dec 8, 2006
Medscape (subscription)...epirubicin, and cyclophosphamide (FEC), 57 stage I breast cancer patients treated with no systemic therapy, and 60 healthy control subjects.

Pharmion Acquires Cabrellis Pharmaceuticals  -  Dec 4, 2006
Pharmaceutical Online (press release),This class of drug includes doxorubicin, daunorubicin and epirubicin, each of which is a close analogue to the others and made semi-synthetically starting

Bortezomib and Thalidomide May Benefit Elderly with Multiple Myeloma  -  Nov 27, 2006
Cancerpage.com,...high-dose dexamethasone proves to be crucial; and liposomal-pegylated doxorubicin seems more effective than both epirubicin and low-dose melphalan."

Teva Announces Agreement with Pfizer Regarding Idarubicin ...  -  12 Dec 2006
Genetic Engineering News (press release),Teva has agreed to make a payment of up to $70 million to Pfizer, which includes an option in 2007 for Teva to sell its own generic version of epirubicin

Abraxis BioScience to present data from six studies at San Antonio ...  -  12 Dec 2006
CNW Telbec (Communiqués de presse),5:00 pm- 7:00 pm Preliminary results from a multicenter phase II trial of biweekly neoadjuvant gemcitabine, epirubicin, ABI-007 (GEA) with correlative

Breast Cancer Regimen Linked to Cognitive Decline  -  12 Dec 2006
Medscape (subscription)...epirubicin, and cyclophosphamide (FEC), 57 stage I breast cancer patients treated with no systemic therapy, and 60 healthy control subjects.

Pharmion Acquires Cabrellis Pharmaceuticals  -  12 Dec 2006
Pharmaceutical Online (press release),This class of drug includes doxorubicin, daunorubicin and epirubicin, each of which is a close analogue to the others and made semi-synthetically starting

Teva, Pfizer Reach Patent Deal  -  12 Dec 2006
TheStreet.comTeva also has an option in 2007 to sell generic epirubicin, a chemotherapy sold by Pfizer as Ellence, prior to the patent expiration next August.

Schaeffer's Today's Market Features: Deere & Co., Advanced Medical ...  -  12 Dec 2006
Business Wire (press release),...million to PFE as part of the settlement, which includes an option for TEVA to sell its own generic version of its cancer mediation epirubicin in 2007.

Pharmion Acquires Cabrellis: $59M For Lung Cancer Drug  -  12 Dec 2006
BioWorld Online,...which let Dainippon scientists make changes that will distinguish it from the likes of doxorubicin, daunorubicin and epirubicin, LeMasters said,

Longer infusion times for anthracyclines reduce cardiac damage  -  Nov 29, 2006
TheHeart.Org,The majority of patients were adults with different types of solid tumors, and the drugs used were doxorubicin, daunorubicin, and epirubicin.

Drug Stocks End Short Week Lower  -  Nov 27, 2006
Forbes,21 it forged an agreement with Pfizer (nyse: PFE - news - people ) regarding the generic sales of idarubicin, azithromycin and epirubicin.

Ten-year Survival of Patients with Localized Inflammatory Breast ...  -  Nov 27, 2006
Cancer Consultants (press release),Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy. Ten year results from the French Adjuvant Study Group GETIS

Sindan exports could reach 15m euros next year  -  Nov 22, 2006
Ziarul Financiar,Among the growth drivers Scheusan mentions the registration and sale of Epirubicin product in Japan and the UK, the company's winning the tender in Bulgaria

Pfizer Ends Suit Against Teva  -  Nov 21, 2006
Wall Street Journal (subscription),...it up to $70 million as part of the settlement, which includes an option for Teva to sell a generic version of another cancer drug, epirubicin, in 2007.

Pfizer, Teva settle patent fight  -  Nov 21, 2006
ReutersThe deal also includes an option in 2007 for Teva to sell its own generic version of another cancer drug, epirubicin, prior to the August 2007 patent expiry

Market Report -- In Play (PFE)  -  Nov 21, 2006
MSN MoneyAs part of the settlement, TEVA will pay up to $70 mln to PFE, which includes an option in 2007 for TEVA to sell its own generic version of epirubicin,

Teva Pharma (TEVA) to Pay $70 Million in Settlement with Pfizer (PFE)  -  Nov 21, 2006
StreetInsider.com (subscription),...includes an option in 2007 for Teva to sell its own generic version of epirubicin, another cancer medication, prior to the August 2007 patent expiry.

Bortezomib and Thalidomide May Benefit Elderly with Multiple Myeloma  -  Nov 27, 2006
Cancerpage.com,...high-dose dexamethasone proves to be crucial; and liposomal-pegylated doxorubicin seems more effective than both epirubicin and low-dose melphalan."

Hospira the sole suitor  -  Nov 21, 2006
Melbourne Herald Sun,...launch of its colorectal cancer drug oxaliplatin in certain European markets and the successful launch of another cancer drug epirubicin in the US.

Hospira's our only takeover offer: Mayne  -  Nov 20, 2006
Sydney Morning Herald,...from the earlier-than-expected launch of its drug oxaliplatin in certain European markets and the successful launch of epirubicin in the United States.

Pharmion Acquires Cabrellis Pharmaceuticals, Gains Rights to ...  -  Nov 16, 2006
PipelineReview.com (press release),This class of drug includes doxorubicin, daunorubicin and epirubicin, each of which is a close analogue to the others and made semi- synthetically starting

Buy Glenmark Pharma for target of Rs 530: Brics PCG  -  Nov 14, 2006
Moneycontrol.com,...(Natural Micronised Progesterone Injection), Milixim LX (Cefixime + Cloxacillin + Lactic acid bacillus), Epithra (Epirubicin) and Taxuba (Docetaxel).�

Studies from Germany, the United States and Greece add new ...  Aug 24, 2006
Study 1: Breast cancer survival could be improved by dose-dense (DD) sequential chemotherapy with epirubicin/paclitaxel then cyclophosphamide, methotrexate ... -Therapeutics Daily (subscription)

YM BioSciences announces independent Data Safety Monitoring Board ...  Aug 22, 2006
...a good safety profile." The pivotal Phase III trial compares the survival of patients treated with tesmilifene combined with epirubicin/cyclophosphamide to ... -CNW Telbec (Communiqués de presse)

YM Bio gets thumbs up for tesmilifene trial  Aug 23, 2006
The pivotal phase III trial compares the survival of patients treated with tesmilifene combined with epirubicin/cyclophosphamide to epirubicin/cyclophosphamide ... -ShareCast

Sindan posts 23.6m-euro sales in Q2  Aug 13, 2006
As shown in the company's quarterly report, the trend was driven by the company's significant sales of Paclitaxel and Epirubicin drugs. ... -Ziarul Financiar

Adjuvant Treatment of Breast Cancer  Aug 1, 2006
...analysis involved patients in the MA.5 trial, [2] a randomized study by the National Cancer Institute of Canada of cyclophosphamide-epirubicin-fluorouracil (CEF ... -Medscape (subscription)

Early Look At The Market – UTR morning view  Aug 21, 2006
...(Bloomberg) Mayne Pharma FDA grants tentative approval for epirubicin HCL injection (PFE's Ellence). OXGN COO Steve Young leaves to pursue other interests. ... -E-Wire

Combination Chemotherapy Followed by Radiation Therapy With or ...  Jul 27, 2006
Compare neoadjuvant fluorouracil, epirubicin, and cyclophosphamide vs docetaxel and epirubicin followed by radiotherapy and surgery in women with locally ... -Community Dispatch

Chemotherapy or Hormone Therapy Result in Similar Survival for ...  Jul 31, 2006
Patients were treated with triptorelin plus tamoxifen (hormone blockade) or fluorouracil, epirubicin and cyclophosphamide (chemotherapy). ... -Cancer Consultants

Cabrellis' $27.5M Series A To Fund Three SCLC Trials  Aug 7, 2006
...it appears to "exert more [topoisomerase II] activity than traditional anthracyclines," which include doxorubicin, daunorubicin and epirubicin, all made semi ... -BioWorld Online



Ovarian cancer outcome did not improve by adding epirubicin to ...  Apr 27, 2006
Ovarian cancer outcome did not improve by adding epirubicin as a third drug to the carboplatin-paclitaxel (TC) chemotherapy regimen. ... - Therapeutics Daily (subscription)

Suggestion of Better Survival with Dose-Dense Chemotherapy in ...  Apr 28, 2006
Half the patients were treated with a dose-dense chemotherapy regimen that consisted of four cycles of epirubicin and paclitaxel at 14-day intervals, followed ... - Cancer Consultants

Gene Profile To Help Decide On Breast Cancer Treatment  Apr 20, 2006
...drugs. An innovative chemotherapy regimen for breast cancer is a combination of gemcitabine, docetaxel and epirubicin. Clinicians ... - Medical News Today

Dose-Dense Adjuvant Chemotherapy for Node-Positive Breast Cancer ...  May 5, 2006
All patients received epirubicin and paclitaxel for four cycles followed by three cycles of cyclophosphamide, methotrexate, and 5-FU (CMF). ... - Cancer Consultants





Reports advance knowledge in gastric cancer research  Apr 6, 2006
Study 1: Biweekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil (PELF) continuous infusion plus G-CSF was deemed feasible in gastric ... - Therapeutics Daily (subscription)

Sanofi-Aventis: Taxotere fighting to maintain blockbuster status  Mar 29, 2006
The current standard treatment consisting of epirubicin in combination with cisplatin and 5-FU offers a median overall survival of 8.9 months. ... - Pharmaceutical Business Review

Arsenic Trioxide Effective as Single Agent in Newly Diagnosed APL  Mar 31, 2006
Standard initial treatment for APL consists of chemotherapy, including an anthracycline (doxorubicin, epirubicin, mitoxantrone, idarubicin) and the agent all ... - Cancer Consultants

Interlocutory Injunctions for Pharmaceutical Patent Infringement  Mar 15, 2006
Under that licence, Pfizer manufactures and sells ready-to-use solutions of doxorubicin hydrochloride and epirubicin hydrochloride. ... - Mondaq News Alerts

(PZ) VioQuest Pharmaceuticals Appoints an Industry Veteran as ...  Mar 15, 2006
...director for Pfizer, where she was responsible for US development of Aromasin, an aromatase inhibitor for breast cancer, and Epirubicin, an anthracycline for ... - Houston Chronicle

Former Texas Gov. Ann Richards has esophagus cancer  Mar 9, 2006
In more recent studies, addition of epirubicin (ECF) was better than other comparable regimens in advanced nonresectable cancer (Ross et al 2002). ... - Food Consumer

Callisto Pharma Expands Research Trial Of Cancer Drug L-Annamycin ...  Mar 21, 2006
...drugs in clinical use today. Compounds in this class include doxorubicin, daunorubicin and epirubicin. These drugs are all close ... - Trading Markets

Genepharm's First Cancer Drugs Approved By TGA, Australia  Mar 11, 2006
The approved drugs, Epirubicin and Carboplatin, are two of the leading drugs used in Australian hospitals for the treatment of cancer. ... - Medical News Today

High-Dose Chemotherapy Improves Outcomes of HER2/neu Negative ...  Mar 13, 2006
...cancer). They were treated with a standard chemotherapy regimen referred to as FEC (5-fluorouracil, epirubicin, cyclophosphamide). ... - Cancer Consultants

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional